Filing Flows › Comparisons › CISO vs PBSV
Ciso Global vs Pharma-Bio Serv: CISO and PBSV compared
Ciso Global is the larger company: $5.8M of revenue in its latest quarter (Q2 2026) against $2.3M for Pharma-Bio Serv (Q3 FY26). Pharma-Bio Serv is growing faster (+19% against -14% a year earlier). Pharma-Bio Serv is more profitable, with an operating margin of -3.1% against -25.7%.
Where the money goes: CISO and PBSV
Ciso Global (CISO) · Q2 2026
Ciso Global, Q2 2026: revenue $5.8M (-14% year over year), operating margin -25.7%, net loss $1.6M, operating cash flow −$69K. The chart follows the revenue to costs, profit and cash.
Pharma-Bio Serv (PBSV) · Q3 FY26
Pharma-Bio Serv, Q3 FY26: revenue $2.3M (+19% year over year), operating margin -3.1%, net loss $14K, operating cash flow $61K. The chart follows the revenue to costs, profit and cash.
| Ciso Global (CISO) | Pharma-Bio Serv (PBSV) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 FY26 |
| Revenue | $5.8M | $2.3M |
| Revenue growth, Y/Y | -14% | +19% |
| Operating margin | -25.7% | -3.1% |
| Net earnings | −$1.6M | −$14K |
| Net margin | -27.8% | -0.6% |
| Operating cash flow | −$69K | $61K |
| Free cash flow | — | $60K |
Where the revenue comes from
Ciso Global
- Security Managed Services: $5.1M (89%)
- Professional Services: $465K (8%)
- Cybersecurity Software: $194K (3%)
Questions
Which is bigger, Ciso Global or Pharma-Bio Serv?
Ciso Global is the larger company: $5.8M of revenue in its latest quarter (Q2 2026) against $2.3M for Pharma-Bio Serv (Q3 FY26).
Is Ciso Global or Pharma-Bio Serv growing faster?
Pharma-Bio Serv is growing faster (+19% against -14% a year earlier).
Which is more profitable, Ciso Global or Pharma-Bio Serv?
Pharma-Bio Serv is more profitable, with an operating margin of -3.1% against -25.7%.
More: Ciso Global earnings · how Ciso Global makes money · Pharma-Bio Serv earnings · how Pharma-Bio Serv makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Sep 14, 2026). Fiscal quarters can end on different dates. Not investment advice.